Trials / Terminated
TerminatedNCT03859648
BONEBRIDGE Bone Conduction Implant in Adults
Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Med-El Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA-cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months post-activation to assess safety and effectiveness of the BONEBRIDGE implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BONEBRIDGE | Bone Conduction Implant |
Timeline
- Start date
- 2019-08-26
- Primary completion
- 2022-11-04
- Completion
- 2022-11-04
- First posted
- 2019-03-01
- Last updated
- 2024-05-30
- Results posted
- 2024-05-30
Locations
3 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03859648. Inclusion in this directory is not an endorsement.